MARIE-CLAUDE GINGRAS to Adenocarcinoma
This is a "connection" page, showing publications MARIE-CLAUDE GINGRAS has written about Adenocarcinoma.
Connection Strength
1.008
-
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep. 2016 Feb 02; 14(4):907-919.
Score: 0.291
-
Basic principles and technologies for deciphering the genetic map of cancer. World J Surg. 2009 Apr; 33(4):615-29.
Score: 0.182
-
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived Analysis. J Natl Compr Canc Netw. 2025 Jun; 23(6):234-240.
Score: 0.139
-
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication. JAMA Surg. 2024 Dec 01; 159(12):1365-1373.
Score: 0.135
-
Somatic mutations of esophageal adenocarcinoma: a comparison between Black and White patients. Sci Rep. 2024 04 18; 14(1):8988.
Score: 0.129
-
The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function. World J Surg. 2011 Aug; 35(8):1715-24.
Score: 0.053
-
Developing a tissue resource to characterize the genome of pancreatic cancer. World J Surg. 2009 Apr; 33(4):723-31.
Score: 0.045
-
High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma. Cancer Immunol Immunother. 1995 Jul; 41(1):1-9.
Score: 0.018
-
Loss of alpha 1 beta 1 and reduced expression of other beta 1 integrins and CAM in lung adenocarcinoma compared with pneumocytes. J Surg Oncol. 1994 Jul; 56(3):198-208.
Score: 0.016